Search Orphan Drug Designations and Approvals
-
| Generic Name: | ibrutinib | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Name: | Imbruvica | ||||||||||||||||
| Date Designated: | 04/06/2012 | ||||||||||||||||
| Orphan Designation: | Treatment of chronic lymphocytic leukemia (CLL) | ||||||||||||||||
| Orphan Designation Status: | Designated/Approved | ||||||||||||||||
| Sponsor: |
Pharmacyclics, LLC 995 E. Arques Avenue Sunnyvale, California 94085 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
||||||||||||||||
Marketing approved: |
|||||||||||||||||
| 1 | Generic Name: | ibrutinib |
|---|---|---|
| Trade Name: | Imbruvica | |
| Marketing Approval Date: | 02/12/2014 | |
| Approved Labeled Indication: | Treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy | |
| Exclusivity End Date: | 02/12/2021 | |
| Exclusivity Protected Indication* : | Treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy | |
| 2 | Generic Name: | ibrutinib |
|---|---|---|
| Trade Name: | Imbruvica | |
| Marketing Approval Date: | 07/28/2014 | |
| Approved Labeled Indication: | Treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy and treatment of patients with chronic lymphocytic leukemia (CLL) with 17p deletion | |
| Exclusivity End Date: | 07/28/2021 | |
| Exclusivity Protected Indication* : | Treatment of chronic lymphocytic leukemia with 17p deletion who have not received at least one prior therapy | |
| 3 | Generic Name: | ibrutinib |
|---|---|---|
| Trade Name: | Imbruvica | |
| Marketing Approval Date: | 03/04/2016 | |
| Approved Labeled Indication: | Indicated for the treatment of patients with chronic lymphocytic leukemia | |
| Exclusivity End Date: | 03/04/2023 | |
| Exclusivity Protected Indication* : | Indicated for the treatment of patients with chronic lymphocytic leukemia without 17p deletion who have not received at least one prior therapy (first line therapy). | |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







